Medicina
Departamento
University Medical Center Freiburg
Friburgo de Brisgovia, AlemaniaPublicaciones en colaboración con investigadores/as de University Medical Center Freiburg (22)
2023
-
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
The European respiratory journal, Vol. 61, Núm. 1
-
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
The Lancet Respiratory Medicine, Vol. 11, Núm. 1, pp. 74-86
-
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) – Proceedings from the SOGLI consortium meeting in rome November 2022
Clinical Nutrition
2022
2021
-
ESPEN practical guideline: Clinical nutrition in chronic intestinal failure
Clinical Nutrition, Vol. 40, Núm. 9, pp. 5196-5220
-
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
Leukemia, Vol. 35, Núm. 3, pp. 835-849
-
Wheat Anaphylaxis in Adults Differs from Reactions to Other Types of Food
Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 7, pp. 2844-2852.e5
2020
-
Characteristics and treatment regimens across ERS SHARP severe asthma registries
European Respiratory Journal, Vol. 55, Núm. 1
-
EAACI-Leitlinien zur allergen-spezifischen Immuntherapie: Insektengiftallergie
Allergologie, Vol. 43, Núm. 5, pp. 176-203
-
Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts
Radiotherapy and Oncology, Vol. 149, pp. 84-88
2019
-
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course
Journal of Clinical Medicine, Vol. 8, Núm. 11
-
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
Radiotherapy and Oncology, Vol. 133, pp. 163-166
2018
-
Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia
Annals of Neurology, Vol. 84, Núm. 5, pp. 729-740
2016
-
Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: Application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 3, pp. 794-802
2015
-
Normal reference values of left ventricular strain using three-dimensional speckle tracking echocardiography: Results from amulticentre study
European Heart Journal Cardiovascular Imaging, Vol. 16, Núm. 4, pp. 410-416
2014
-
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: Prevalence and survival - An analysis of data from the ERA-EDTA Registry
Nephrology Dialysis Transplantation, Vol. 29, pp. iv15-iv25
2011
-
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: The SEISMIC trial
EuroIntervention, Vol. 6, Núm. 7, pp. 805-812
-
Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study
The Lancet Oncology, Vol. 12, Núm. 8, pp. 795-805
2009
-
A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration
Transplantation, Vol. 88, Núm. 9, pp. 1101-1108
-
Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention. 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial
JACC: Cardiovascular Interventions, Vol. 2, Núm. 11, pp. 1083-1091